Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Once a Scientist

Once a Scientist artwork

98. Renee Wegrzyn and Anna Marie Wagner, Founders of Transfyr, on Why Science's Reproducibility Problem Isn't in the Lab Notebook

Sep 15, 202651 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Renee Wegrzyn, PhD, is co-founder of Transfyr AI. Recognized as a TIME 100 Innovator, Rock Health Top 50 Digital Health Innovator, and recipient of the Superior Public Service Medal, Renee holds a BS and PhD in Applied Biology and Bioengineering from Georgia Tech. She spent over a decade at DARPA, including as a program manager focused on gene editing and biomanufacturing and as a technical advisor to IARPA, where she ran "moonshot" programs. She later became VP of Business Development & Head of Innovation (Biosecurity) at Ginkgo Bioworks. Anna Marie Wagner is co-founder of Transfyr AI. She holds a B.A. in Applied Mathematics from Harvard University and an MBA from Harvard Business School. She spent nearly a decade at Bain Capital Private Equity, eventually focusing on vertical software, before joining the executive team at Ginkgo Bioworks. She built out Ginkgo's AI team and oversaw major strategic transactions, including the 2021 IPO (raised $1.6B - reportedly the largest-ever go-public raise in biotech). Learn more about Transfyr in the recent NYTimes feature: https://www.nytimes.com/2026/08/27/science/scientists-experiments-replication-ai.html

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. 99. Melissa Crisp, Senior Director at Eli Lilly and President of SLAS, on How AI and Automation Are Reshaping Drug Discovery

    Oct 21, 202643 minAudio

    Melissa Crisp, Ph.D. is a Senior Director in Biologics Screening and Automation Technologies at Eli Lilly and Company in San Diego, where she leads a team applying innovative automation and screening technologies to...

    Credit the people on this episode

  2. 97. Ron Alfa, CEO of NOETIK, on Biology as a Search Problem

    Aug 18, 202646 minAudio

    Ron is Co-Founder and CEO of NOETIK, a next generation precision oncology company using multimodal foundation models pre-trained on large-scale human tumor data to discover cancer therapeutics. He holds an MD and PhD...

    Credit the people on this episode

  3. 96. Chris Anderson, Advisor to Pillar VC and former Wired Editor, on How Adjacent Technologies Will Transform Lab Automation

    Jul 29, 202641 minAudio

    Chris Anderson currently serves as an advisor at Pillar VC and Renaissance Philanthropy. He was editor of WIRED and spent seven years at The Economist, where he worked as editor of both the technology and business...

    Credit the people on this episode

  4. 95. Stacie Calad-Thomson, Head of BioPharma Labs and Manufacturing BD at NVIDIA, on AI as an endless collaborator

    Jun 10, 202645 minAudio

    Stacie Calad-Thomason is Head of BioPharma Labs and Manufacturing Business Development at NVIDIA. She has a PhD in Chemistry from UC Irvine and a B.A. in Chemistry from UC Berkeley. Topics & Timecodes: Physical AI Tools...

    Credit the people on this episode

  5. 94. Ira Hoffman, CEO of HighRes on robots, digital twins and how we will speed up science

    May 6, 202643 minAudio

    Ira Hoffman is the CEO of HighRes. He has a M.S. in Computer Science and a B.A. in Physics/Mathematics from the University of Vermont. OUTLINE: [00:00] - Introduction to collaborative robots and safe human-robot...

    Credit the people on this episode